Category: Top Story
-
What Is the Biggest Obstacle to a SpaceX-Tesla Merger? JPMorgan Points to China
Why does JPMorgan consider Chinese regulatory approval the main obstacle to a SpaceX-Tesla merger? JPMorgan believes obtaining regulatory approval in China could represent the most significant challenge to a potential merger between Tesla (NASDAQ:TSLA) and SpaceX, outweighing the difficulties associated with securing support from Tesla shareholders. In a research note published Wednesday, JPMorgan analyst Rajat…
-
US Stock Futures Drop After Tesla, Meta & IBM Earnings Drop: Dow Jones, S&P and Nasdaq Futures
U.S. index futures point to a sharply lower open on Thursday as investors take profits from Tesla, Meta, and IBM following earnings, alongside growing AI capital spending concerns. Dow Jones, S&P 500 and Nasdaq futures are currently pointing to a sharply lower open on Thursday, with stocks likely to give back ground after trending higher…
-
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission, PDUFA Date of March 25, 2027
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.
-
Tech Rally Lifts Wall Street as SpaceX Surges
U.S. stocks finished higher on Wednesday, with technology shares leading the way as investors cheered strong quarterly results from SpaceX and positioned ahead of earnings from Tesla and Meta after the closing bell. All three major averages gained despite a jump in oil prices tied to an attack on a Saudi Aramco field, suggesting investors…
-
Software stocks gain as market warning signals flash
Bruce Campbell examines the rotation from semiconductors into software, weakening US banking stocks and fresh warning signals across equity markets.
-
Manufacturing Progress Gives INmune Bio a Clearer UK Filing Path for Ebstrocel
INmune Bio (NASDAQ:INMB) is advancing its European commercialization strategy for Ebstrocel, leveraging chemistry, manufacturing, and controls (CMC) progress to streamline its regulatory timeline and accelerate potential entry into the UK market. By submitting its final pre-marketing authorization application (pre-MAA) package to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), the biotechnology company confirmed a…
-
Why Is Netflix Stock Falling Over 5% Despite Beating Third-Quarter Earnings Estimates?
Why did Netflix shares decline in pre-market trading? Netflix (NASDAQ:NFLX) shares fell more than 5% in pre-market trading after the streaming company issued fourth-quarter revenue guidance below Wall Street expectations, despite reporting third-quarter earnings above analysts’ forecasts. The company also reduced its annual advertising revenue outlook, citing delays in the introduction of certain advertising products.…
-
Why Is AT&T Stock Falling Despite Beating Third-Quarter Earnings Estimates?
Why did AT&T shares decline in pre-market trading? AT&T Inc. (NYSE:T) shares fell 3.3% in pre-market trading on Wednesday following the release of its third-quarter 2026 financial results, despite the telecommunications company reporting earnings and revenue above Wall Street expectations. The company also increased its full-year adjusted earnings guidance and maintained its free cash flow…
-
Philip Morris Shares Fall 2.5% Despite Q3 Earnings Beat as Investors Assess 2026 Outlook
Philip Morris International (NYSE:PM) shares declined 2.48% in pre-market trading on Wednesday despite the tobacco company reporting third-quarter 2026 earnings and revenue above analysts’ expectations, as investors assessed its full-year guidance and the impact of rising operating costs. The company reported adjusted earnings per share of $2.36, exceeding the consensus estimate of $2.30 by $0.06.…
-
Wall Street Futures Rise as Corporate Earnings Support Technology Stocks: Dow Jones, S&P, Nasdaq
US stock index futures pointed to a higher opening on Wednesday, suggesting Wall Street could extend its gains from recent sessions as investors assessed quarterly earnings reports and prepared for further results from major technology companies. Technology stocks were expected to contribute to the early advance, although individual companies recorded contrasting pre-market movements following their…